Table 2.
Change in symptoms across intervention and control groups after 160 days of participation*
| Symptom | Day 160: intervention − control (95% CI) | P | Control: day 160 − baseline (95% CI) | P | Intervention: day 160 − baseline (95% CI) | P |
|---|---|---|---|---|---|---|
| Average fatigue | −0.09 (−1.73 to 1.55) | .911 | 1.36 (−0.04 to 2.76) | .056 | 1.19 (0.10 to 2.27) | .033 |
| Fatigue interference | −0.47 (−2.51 to 1.57) | .651 | 2.03 (0.45 to 3.61) | .012 | 1.66 (0.34 to 2.98) | .014 |
| Average pain severity | −1.28 (−2.79 to 0.22) | .095 | 1.98 (0.88 to 3.08) | <.001 | 0.22 (−0.62 to 1.06) | .604 |
| Pain interference | −1.36 (−3.44 to 0.73) | .201 | 2.73 (1.20 to 4.25) | <.001 | 0.82 (−0.40 to 2.05) | .188 |
| Depression summary | 1.85 (−4.13 to 7.84) | .544 | −4.50 (−8.72 to −0.28) | .037 | −3.19 (−6.51 to 0.12) | .059 |
* CI = confidence interval.